Tiankang Biotech announced that the 11th meeting of the 9th board of directors of the company reviewed and passed the “Proposal to Change the Accounting Firm”, with 6 votes in agreement, 0 votes against, and 0 abstentions. The bill has been reviewed and passed by the Audit Committee of the Board of Directors and a special meeting of independent directors, and still needs to be submitted to the 6th Extraordinary General Meeting of Shareholders in 2026. At the same time, the meeting deliberated and passed a proposal for the holding subsidiary to sign a strategic purchasing and sales cooperation agreement and related transactions. The bill also needs to be submitted to the Extraordinary Shareholders' Meeting for consideration; the meeting also reviewed and passed the bill to hold the 6th Extraordinary Shareholders' Meeting in 2026.

Tiankang Biotech announced that the 11th meeting of the 9th board of directors of the company reviewed and passed the “Proposal to Change the Accounting Firm”, with 6 votes in agreement, 0 votes against, and 0 abstentions. The bill has been reviewed and passed by the Audit Committee of the Board of Directors and a special meeting of independent directors, and still needs to be submitted to the 6th Extraordinary General Meeting of Shareholders in 2026. At the same time, the meeting deliberated and passed a proposal for the holding subsidiary to sign a strategic purchasing and sales cooperation agreement and related transactions. The bill also needs to be submitted to the Extraordinary Shareholders' Meeting for consideration; the meeting also reviewed and passed the bill to hold the 6th Extraordinary Shareholders' Meeting in 2026.